TMFFishBiz’s Activity

Sat Jan 14

NL

Article

TMFFishBiz published an article 11:41 AM

Should Investors Bet on Gilead Sciences Version 3.0?

Intercept Pharmaceuticals' presentation at the J.P. Morgan Healthcare Conference could give a sneak peek at the future for Gilead Sciences.

Fri Jan 13

NL

Article

TMFFishBiz published an article 2:41 PM

7 Impressive Numbers for Intuitive Surgical, Inc.

Intuitive Surgical's CEO talks at the J.P. Morgan Healthcare Conference about the company's past -- and future -- success. The numbers don't lie.

NL

Article

TMFFishBiz published an article 12:02 PM

Why Exact Sciences' Stock Could Go Much Higher

Exact Sciences CEO discusses the company's huge opportunities at the J. P. Morgan Healthcare Conference.

Thu Jan 12

NL

Article

TMFFishBiz published an article 3:22 PM

It's Full Speed Ahead for Opko Health After Pipeline Stumble

Opko Health talks about its momentum and a second chance for its human growth hormone at the J. P. Morgan Healthcare Conference.

NL

Article

TMFFishBiz published an article 9:03 AM

7 Reasons AbbVie's Stock Could Soar in 2017

AbbVie's CEO discusses multiple potential catalysts for the company -- and its stock -- at the J. P. Morgan Healthcare conference.

Wed Jan 11

NL

Article

TMFFishBiz published an article 4:41 PM

Valeant Pharmaceuticals: Separating Fact From Fiction

Valeant's CEO said at the J.P. Morgan Healthcare Conference that his company is poised for a turnaround. Is he right?

NL

Article

TMFFishBiz published an article 4:22 PM

3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference

Pfizer executives discuss acquisitions, taxes, and competition at the J. P. Morgan Healthcare Conference this week.

NL

Article

TMFFishBiz published an article 9:41 AM

3 Charts Every Bristol-Myers Squibb Shareholder Needs to See

Bristol-Myers Squibb's CEO gives reasons to be optimistic about the stock at the J.P. Morgan Healthcare Conference.

Tue Jan 10

NL

Article

TMFFishBiz published an article 5:41 PM

Johnson & Johnson CEO's Fireside Chat: 5 Things You Need to Know

Johnson & Johnson CEO Alex Gorsky talks about the big picture at the J. P. Morgan Healthcare Conference.

NL

Article

TMFFishBiz published an article 5:03 PM

What Sarepta Therapeutics' CEO Said That Made the Stock Soar

Sarepta Therapeutics' CEO gives reasons for investors to celebrate at the J.P. Morgan Healthcare Conference.

NL

Article

TMFFishBiz published an article 10:03 AM

3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock

Ionis Pharmaceuticals' presentation at the J.P. Morgan Healthcare Conference highlights several reasonsthis biotech stock is a buy in 2017.

NL

Article

TMFFishBiz published an article 7:23 AM

Incyte's Prospects Get Even Brighter With Merck Announcement

Incyte announces good news before and during its presentation at the J.P. Morgan Healthcare Conference.

NL

Article

TMFFishBiz published an article 7:03 AM

Better Buy: Welltower Inc. vs. National Health Investors Inc.

Which healthcare REIT stock wins in a head-to-head match-up between Welltower and National Health Investors?

Mon Jan 9

NL

Article

TMFFishBiz published an article 10:02 PM

5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond

Vertex CEO Jeff Leiden details how the company will succeed going forward at the J.P. Morgan Healthcare Conference.

NL

Article

TMFFishBiz published an article 6:03 PM

4 Things Gilead Sciences' CEO Says to Expect in 2017

CEO John Milligan didn't announce any surprises at the J.P. Morgan Healthcare Conference on Monday.

NL

Article

TMFFishBiz published an article 2:23 PM

Is Celgene Simply the Best Biotech Stock on the Planet?

Celgene wows yet again at the J.P. Morgan Healthcare Conference.

NL

Article

TMFFishBiz published an article 9:43 AM

Better Buy: Myriad Genetics vs. Exact Sciences

Myriad Genetics and Exact Sciences both face challenges. But which of these molecular diagnostics stocks presents the best long-term opportunity for investors?

NL

Article

TMFFishBiz published an article 8:22 AM

Here's a Biotech IPO You'll Want to Watch

Celgene has already invested in Jounce Therapeutics. Soon, everyone else will get a chance.

Sun Jan 8

NL

Article

TMFFishBiz published an article 11:01 AM

Start the New Year off Right with 3 Best Biotech Stocks

Here's why Celgene, Jazz Pharmaceuticals, and Synergy Pharmaceuticals could make 2017 a happy New Year for investors.

NL

Article

TMFFishBiz published an article 7:21 AM

3 Stocks Expected to More Than Double Their Earnings in 2017

Wall Street has high expectations in the coming year for Corcept Therapeutics, Incyte, and Exelixis.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 74693
Score 0.00
Score Change Today +9.87
Accuracy 0.00%
Active Picks 6
Total Picks 19
Best Pick QCOR.DL (+221.68)
Worst Pick AMRN (-107.70)
Average Score per Pick -6.83
Charms Earned 2
Highest Rated Favorite No Favorites Selected
Go to TMFFishBiz’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFFishBiz’s 10 Latest Posts